![EHA Tutorial on Recent Advances in Lymphoid and Myeloid Malignancies](https://oncodaily.com/pub/uploads/2024/09/IMG_5086.jpeg)
EHA Tutorial on Recent Advances in Lymphoid and Myeloid Malignancies
The Kazakh Cancer Society and the Kazakh Research Institute of Oncology and Radiology, in collaboration with the European Association of Hematologists, will present an international tutorial.
The event will be held from 13 to 15 September 2024, in Almaty.
Dilyara Kaidarova is the Chairman of the board at the Kazakh Institute Of Oncology and Radiology. Dilyara Kaidarova, as the Director of KazIOR, spearheaded the adoption of the National Cancer Control Plan.
Dilyara has successfully combined extensive clinical responsibilities with research work in oncology, leading to her election to the Lancet Commission, ASCO International Affairs, and the IGCS Council of Asia and Oceania. Dilyara Kaidarova graduated from the Kazakh Medical Institute and has 30 years of experience in the field.
The program of the international tutorial includes the following topics:
– prevention and early diagnosis of hematological diseases,
– new achievements in the diagnosis of hematological diseases;
– modern medical technologies for the treatment of hemoblastoses;
– high-tech methods of targeted therapy;
– pathomorphological features of lymphomatoid papulosis;
– prospects for the development of assistance to hematological patients.
The format of the event will allow discussing clinical cases and exchanging opinions with global experts.
The event will be attended by more than 200 hematologists, oncologists and pathologists from Central Asian countries and abroad.
Format: hybrid
Venue: Almaty, Rahat Palace Hotel, Satpayev St. 29/6
Registration information here.
The meeting will be broadcasted online on the website, hybrid format.
For more posts like this, visit oncodaily.com.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023